Article info
PDFTranslational medicine: brief reports
The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications
- Dr M D Säemann, Department of Internal Medicine III, Clinical Division of Nephrology and Dialysis, Medical University Vienna, Währinger Gürtel 18–20, A-1090 Vienna, Austria; marcus.saemann{at}meduniwien.ac.at
Citation
The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications
Publication history
- Accepted July 17, 2008
- First published November 20, 2008.
Online issue publication
November 20, 2008
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group and European League Against Rheumatism